Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 5
2022 7
2023 7
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register.
Thunberg J, Björkqvist O, Hedin CRH, Forss A, Söderman C, Bergemalm D; SWIBREG Study Group; Olén O, Hjortswang H, Strid H, Ludvigsson JF, Eriksson C, Halfvarson J. Thunberg J, et al. United European Gastroenterol J. 2022 Sep;10(7):631-639. doi: 10.1002/ueg2.12275. Epub 2022 Jul 14. United European Gastroenterol J. 2022. PMID: 35834389 Free PMC article.
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG.
Eriksson C, Visuri I, Vigren L, Nilsson L, Kärnell A, Hjortswang H, Bergemalm D; GO SWIBREG study group; Almer S, Hertervig E, Karlén P, Strid H, Halfvarson J. Eriksson C, et al. Scand J Gastroenterol. 2021 Nov;56(11):1304-1311. doi: 10.1080/00365521.2021.1963466. Epub 2021 Aug 20. Scand J Gastroenterol. 2021. PMID: 34415803 Free article.
Cumulative incidence and prevalence of perianal diseases in patients with inflammatory bowel disease and in the population: a nationwide Swedish study.
Everhov ÅH, Eberhardson M, Söderling J, Nordenvall C, Halfvarson J, Ludvigsson JF, Olén O, Myrelid P; SWIBREG study group; Strid H, Hjortswang H, Olsson M, Bengtsson JL, Andersson MA, Karling P, Rejler M, Jäghult S, Fagerberg UL, Mårild K, Hreinsson J, Hedin C. Everhov ÅH, et al. Scand J Gastroenterol. 2025 Apr;60(4):349-354. doi: 10.1080/00365521.2025.2476669. Epub 2025 Mar 17. Scand J Gastroenterol. 2025. PMID: 40094394 Free article.
Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden.
Everhov ÅH, Söderling J, Befrits G, Khalili H, Bröms G, Neovius M; SWIBREG study group; Askling J, Halfvarson J, Ludvigsson JF, Olén O. Everhov ÅH, et al. Aliment Pharmacol Ther. 2023 Oct;58(7):692-703. doi: 10.1111/apt.17675. Epub 2023 Aug 18. Aliment Pharmacol Ther. 2023. PMID: 37594381 Free article.
31 results